Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison-Reference-Cited by-同舟云学术

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison

Published:2012-11-20 Issue:4 Volume:21 Page:1097-1103
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Phillips Kristin M.,Pinilla-Ibarz Javier,Sotomayor Eduardo,Lee Morgan R.,Jim Heather S. L.,Small Brent J.,Sokol Lubomir,Lancet Jeffrey,Tinsley Sara,Sweet Kendra,Komrokji Rami,Jacobsen Paul B.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-012-1630-5.pdf

Reference23 articles.

1. O'Brien SG, Guilhot F, Larson RA et al (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348(11):994–1004

2. Hahn EA, Glendenning GA, Sorensen MV et al (2003) Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study. J Clin Oncol 21(11):2138–2146

3. Aziz Z, Iqbal J, Aaqib M et al (2011) Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia. Leuk Lymphoma 52(6):1017–1023

4. Agrawal M, Garg RJ, Cortes J et al (2010) Tyrosine kinase inhibitors: the first decade. Curr Hematol Malig Rep 5(2):70–80

5. Pinilla-Ibarz J, Cortes J, Mauro MJ (2011) Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: definitions and clinical implications. Cancer 117(4):688–697

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of a Short-Term Supervised Exercise Program in Women with Breast Cancer;Applied Sciences;2024-07-26

2. Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety;Expert Opinion on Drug Safety;2024-06-17

3. Mechanism and application of acupuncture and electro‐acupuncture associated with cancer therapy;MedComm – Oncology;2024-05-19

4. Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97);Frontiers in Oncology;2024-02-21

5. Systematic review and meta-analysis of the effectiveness of expressive writing disclosure on cancer and palliative care patients’ health-related outcomes;Supportive Care in Cancer;2023-12-29